BCTX
Price
$11.00
Change
+$0.29 (+2.71%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
19.49M
PTCHF
Price
$1.55
Change
-$0.27 (-14.84%)
Updated
Sep 2 closing price
Capitalization
407.69M
Interact to see
Advertisement

BCTX vs PTCHF

Header iconBCTX vs PTCHF Comparison
Open Charts BCTX vs PTCHFBanner chart's image
Briacell Therapeutics Corp NEW
Price$11.00
Change+$0.29 (+2.71%)
Volume$1K
Capitalization19.49M
PureTech Health
Price$1.55
Change-$0.27 (-14.84%)
Volume$3K
Capitalization407.69M
BCTX vs PTCHF Comparison Chart in %
Loading...
BCTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTCHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCTX vs. PTCHF commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCTX is a Buy and PTCHF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (BCTX: $11.00 vs. PTCHF: $1.55)
Brand notoriety: BCTX and PTCHF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCTX: 76% vs. PTCHF: 53%
Market capitalization -- BCTX: $19.02M vs. PTCHF: $407.69M
BCTX [@Biotechnology] is valued at $19.02M. PTCHF’s [@Biotechnology] market capitalization is $407.69M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCTX’s FA Score shows that 1 FA rating(s) are green whilePTCHF’s FA Score has 1 green FA rating(s).

  • BCTX’s FA Score: 1 green, 4 red.
  • PTCHF’s FA Score: 1 green, 4 red.
According to our system of comparison, PTCHF is a better buy in the long-term than BCTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCTX’s TA Score shows that 5 TA indicator(s) are bullish while PTCHF’s TA Score has 5 bullish TA indicator(s).

  • BCTX’s TA Score: 5 bullish, 4 bearish.
  • PTCHF’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, PTCHF is a better buy in the short-term than BCTX.

Price Growth

BCTX (@Biotechnology) experienced а +20.22% price change this week, while PTCHF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.14%. For the same industry, the average monthly price growth was +9.25%, and the average quarterly price growth was +54.64%.

Industries' Descriptions

@Biotechnology (+4.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PTCHF($408M) has a higher market cap than BCTX($19.5M). PTCHF YTD gains are higher at: -22.500 vs. BCTX (-87.021). PTCHF has more cash in the bank: 322M vs. BCTX (44.5M). BCTX has less debt than PTCHF: BCTX (27K) vs PTCHF (20.9M).
BCTXPTCHFBCTX / PTCHF
Capitalization19.5M408M5%
EBITDAN/A37.8M-
Gain YTD-87.021-22.500387%
P/E RatioN/A9.12-
RevenueN/A6.17M-
Total Cash44.5M322M14%
Total Debt27K20.9M0%
FUNDAMENTALS RATINGS
BCTX vs PTCHF: Fundamental Ratings
BCTX
PTCHF
OUTLOOK RATING
1..100
2735
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
43
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10051
PRICE GROWTH RATING
1..100
6585
P/E GROWTH RATING
1..100
130
SEASONALITY SCORE
1..100
n/a90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PTCHF's Valuation (43) in the null industry is somewhat better than the same rating for BCTX (96). This means that PTCHF’s stock grew somewhat faster than BCTX’s over the last 12 months.

PTCHF's Profit vs Risk Rating (100) in the null industry is in the same range as BCTX (100). This means that PTCHF’s stock grew similarly to BCTX’s over the last 12 months.

PTCHF's SMR Rating (51) in the null industry is somewhat better than the same rating for BCTX (100). This means that PTCHF’s stock grew somewhat faster than BCTX’s over the last 12 months.

BCTX's Price Growth Rating (65) in the null industry is in the same range as PTCHF (85). This means that BCTX’s stock grew similarly to PTCHF’s over the last 12 months.

BCTX's P/E Growth Rating (1) in the null industry is in the same range as PTCHF (30). This means that BCTX’s stock grew similarly to PTCHF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BCTXPTCHF
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
62%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
64%
Momentum
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
64%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
58%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
60%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
69%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
N/A
Declines
ODDS (%)
Bearish Trend 23 days ago
84%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
69%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 3 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
BCTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PTCHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RJF175.713.82
+2.22%
Raymond James Financial
SGHT3.460.03
+0.87%
Sight Sciences
NHI79.750.04
+0.05%
National Health Investors
DCBO27.84-0.51
-1.80%
Docebo
BURU0.12-0.01
-10.14%
Nuburu Inc.

BCTX and

Correlation & Price change

A.I.dvisor tells us that BCTX and KROS have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BCTX and KROS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCTX
1D Price
Change %
BCTX100%
+2.71%
KROS - BCTX
28%
Poorly correlated
+1.46%
PDSB - BCTX
27%
Poorly correlated
-0.97%
LGVN - BCTX
26%
Poorly correlated
+0.44%
GNPX - BCTX
25%
Poorly correlated
-3.48%
PLRX - BCTX
24%
Poorly correlated
+5.90%
More

PTCHF and

Correlation & Price change

A.I.dvisor tells us that PTCHF and PHGE have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PTCHF and PHGE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTCHF
1D Price
Change %
PTCHF100%
N/A
PHGE - PTCHF
22%
Poorly correlated
+0.58%
BCTX - PTCHF
22%
Poorly correlated
+3.08%
ACET - PTCHF
20%
Poorly correlated
+0.14%
SBMFF - PTCHF
18%
Poorly correlated
N/A
RVXCF - PTCHF
10%
Poorly correlated
+3.69%
More